Join the DDA or

Q3 Category M wipes £23.3m off reimbursement

493 prices down

September 22nd 2020

Tagged: DM Zone news England Wales

By Ailsa Colquhoun

The Department of Health and Social Care has published the quarter three  (October-December 2020) category M prices. The effect of the adjustment is to reduce medicine margin downwards by £23.3 million per quarter (£7.77 million per month).

In summary in the third quarter, there are:

  • 493 prices have fallen, 28 by at least 25 per cent
  • 141 prices have risen, six by more than 50 per cent
  • Two additions and two deletions

Additions:

Bimatoprost 100micrograms/ml eye drops3
Tamsulosin 400microgram / Dutasteride 500microgram capsules30

Deletions

Diamorphine 10mg powder for solution for injection ampoules5
Nizatidine 150mg capsules30

The five biggest % price reductions are:

Hydrocortisone 1% cream303.12-39%
Hydrocortisone 1% cream505.2-39%
Tizanidine 2mg tablets12014.03-41%
Rizatriptan 10mg orodispersible tablets sugar free33.05-41%
Vardenafil 20mg tablets48.2-53%

The five biggest % price increases are:

Co-fluampicil 250mg/250mg capsules2818.18466%
Sertraline 100mg tablets285.89196%
Valaciclovir 500mg tablets1024.11190%
Sertraline 50mg tablets284.22172%
Exemestane 25mg tablets3020.98145%

DDA members can view the full  spreadsheet with history, sorted by price, price increase, and percentage price increase by visiting the online library of Category M updates.

Further information on the adjustment is available from PSNC.